High-risk MSM from Latin America prefer long-acting injectable PrEP (ImPrEP Study Group)
Poster presented by ImPrEP at the 23rd International AIDS Conferencehttps://1395cf30-9035-4b27-b33f-738f50602472.filesusr.com/ugd/f93c93_48f71dc9535b42999c67514b77429e46.pdf